by Norlase | Dec 17, 2025 | News
Home / Archives for Norlase Reports Breakthrough Year in 2025 With Over 40% Global Install Base Growth, Major Regulatory Wins, Strategic Financing, and Industry-Defining Innovation Norlase • DECEMBER 17, 2025 • news Home / Archives for Norlase Reports...
by Norlase | Feb 27, 2025 | News
Home / Archives for Norlase Secures €20 Million EIB Venture Debt to Advance Ophthalmic Laser Technology Norlase • FEBRUARY 27, 2025 • news Photo Credit: Davy Denke Home / Archives for Norlase Secures €20 Million EIB Venture Debt to Advance Ophthalmic Laser...
by Norlase | Feb 8, 2025 | News
Home / Archives for Norlase Appoints New Chairman to Lead Board of Directors Norlase • FEBRUARY 10, 2025 ...
by Norlase | Feb 1, 2025 | News
Home / Archives for Norlase Wins PRISM Award for LYNX™ Pattern LIO Norlase • FEBRUARY 3, 2025 • news Home / Archives for Norlase Wins PRISM Award for LYNX™ Pattern LIO Norlase • FEBRUARY 3, 2025 • news Ballerup, Denmark and Redwood City, CA, USA –...
by Norlase | Jan 22, 2025 | News
Home / Archives for Norlase Receives FDA 510(k) Clearance and CE Mark for LYNX™ Pattern Scanning Laser Indirect Ophthalmoscope Norlase • JANUARY 27, 2025 • news Home / Archives for Norlase Receives FDA 510(k) Clearance and CE Mark for LYNX™ Pattern Scanning...
